Nonerosive Reflux Disease Treatment Market, Global Outlook and Forecast 2022-2028

July 2024 | 69 pages | ID: NBC92DE90C00EN
Market Monitor Global

Abstracts

Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD).

This report contains market size and forecasts of Nonerosive Reflux Disease Treatment in Global, including the following market information:

Global Nonerosive Reflux Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Nonerosive Reflux Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Proton pump inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Nonerosive Reflux Disease Treatment include AstraZeneca, Eisai, GlaxoSmithKline, Takeda Pharmaceutical, Johnson & Johnson, Daewoong Pharmaceutical, Ironwood Pharmaceuticals, SRS Pharmaceuticals and SFJ Pharmaceuticals Group. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nonerosive Reflux Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Nonerosive Reflux Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Nonerosive Reflux Disease Treatment Market Segment Percentages, by Type, 2021 (%)

• Proton pump inhibitors
• H2 Receptor Antagonists
• Antacids
• Others

Global Nonerosive Reflux Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Nonerosive Reflux Disease Treatment Market Segment Percentages, by Application, 2021 (%)

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Global Nonerosive Reflux Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Nonerosive Reflux Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Nonerosive Reflux Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Nonerosive Reflux Disease Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Eisai
• GlaxoSmithKline
• Takeda Pharmaceutical
• Johnson & Johnson
• Daewoong Pharmaceutical
• Ironwood Pharmaceuticals
• SRS Pharmaceuticals
• SFJ Pharmaceuticals Group

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Nonerosive Reflux Disease Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Nonerosive Reflux Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NONEROSIVE REFLUX DISEASE TREATMENT OVERALL MARKET SIZE

2.1 Global Nonerosive Reflux Disease Treatment Market Size: 2021 VS 2028
2.2 Global Nonerosive Reflux Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Nonerosive Reflux Disease Treatment Players in Global Market
3.2 Top Global Nonerosive Reflux Disease Treatment Companies Ranked by Revenue
3.3 Global Nonerosive Reflux Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Nonerosive Reflux Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Nonerosive Reflux Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nonerosive Reflux Disease Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Nonerosive Reflux Disease Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Nonerosive Reflux Disease Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Nonerosive Reflux Disease Treatment Market Size Markets, 2021 & 2028
  4.1.2 Proton pump inhibitors
  4.1.3 H2 Receptor Antagonists
  4.1.4 Antacids
  4.1.5 Others
4.2 By Type - Global Nonerosive Reflux Disease Treatment Revenue & Forecasts
  4.2.1 By Type - Global Nonerosive Reflux Disease Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Nonerosive Reflux Disease Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Nonerosive Reflux Disease Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Nonerosive Reflux Disease Treatment Market Size, 2021 & 2028
  5.1.2 Retail Pharmacies
  5.1.3 Hospital Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Nonerosive Reflux Disease Treatment Revenue & Forecasts
  5.2.1 By Application - Global Nonerosive Reflux Disease Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Nonerosive Reflux Disease Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Nonerosive Reflux Disease Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Nonerosive Reflux Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Nonerosive Reflux Disease Treatment Revenue & Forecasts
  6.2.1 By Region - Global Nonerosive Reflux Disease Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Nonerosive Reflux Disease Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Nonerosive Reflux Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Nonerosive Reflux Disease Treatment Revenue, 2017-2028
  6.3.2 US Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.3.3 Canada Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.3.4 Mexico Nonerosive Reflux Disease Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Nonerosive Reflux Disease Treatment Revenue, 2017-2028
  6.4.2 Germany Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.4.3 France Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.4.4 U.K. Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.4.5 Italy Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.4.6 Russia Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.4.8 Benelux Nonerosive Reflux Disease Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Nonerosive Reflux Disease Treatment Revenue, 2017-2028
  6.5.2 China Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.5.3 Japan Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.5.4 South Korea Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.5.6 India Nonerosive Reflux Disease Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Nonerosive Reflux Disease Treatment Revenue, 2017-2028
  6.6.2 Brazil Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.6.3 Argentina Nonerosive Reflux Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Nonerosive Reflux Disease Treatment Revenue, 2017-2028
  6.7.2 Turkey Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.7.3 Israel Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Nonerosive Reflux Disease Treatment Market Size, 2017-2028
  6.7.5 UAE Nonerosive Reflux Disease Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Nonerosive Reflux Disease Treatment Major Product Offerings
  7.1.4 AstraZeneca Nonerosive Reflux Disease Treatment Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 Eisai
  7.2.1 Eisai Corporate Summary
  7.2.2 Eisai Business Overview
  7.2.3 Eisai Nonerosive Reflux Disease Treatment Major Product Offerings
  7.2.4 Eisai Nonerosive Reflux Disease Treatment Revenue in Global Market (2017-2022)
  7.2.5 Eisai Key News
7.3 GlaxoSmithKline
  7.3.1 GlaxoSmithKline Corporate Summary
  7.3.2 GlaxoSmithKline Business Overview
  7.3.3 GlaxoSmithKline Nonerosive Reflux Disease Treatment Major Product Offerings
  7.3.4 GlaxoSmithKline Nonerosive Reflux Disease Treatment Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline Key News
7.4 Takeda Pharmaceutical
  7.4.1 Takeda Pharmaceutical Corporate Summary
  7.4.2 Takeda Pharmaceutical Business Overview
  7.4.3 Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Major Product Offerings
  7.4.4 Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Revenue in Global Market (2017-2022)
  7.4.5 Takeda Pharmaceutical Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson Nonerosive Reflux Disease Treatment Major Product Offerings
  7.5.4 Johnson & Johnson Nonerosive Reflux Disease Treatment Revenue in Global Market (2017-2022)
  7.5.5 Johnson & Johnson Key News
7.6 Daewoong Pharmaceutical
  7.6.1 Daewoong Pharmaceutical Corporate Summary
  7.6.2 Daewoong Pharmaceutical Business Overview
  7.6.3 Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Major Product Offerings
  7.6.4 Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Revenue in Global Market (2017-2022)
  7.6.5 Daewoong Pharmaceutical Key News
7.7 Ironwood Pharmaceuticals
  7.7.1 Ironwood Pharmaceuticals Corporate Summary
  7.7.2 Ironwood Pharmaceuticals Business Overview
  7.7.3 Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Major Product Offerings
  7.7.4 Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue in Global Market (2017-2022)
  7.7.5 Ironwood Pharmaceuticals Key News
7.8 SRS Pharmaceuticals
  7.8.1 SRS Pharmaceuticals Corporate Summary
  7.8.2 SRS Pharmaceuticals Business Overview
  7.8.3 SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Major Product Offerings
  7.8.4 SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue in Global Market (2017-2022)
  7.8.5 SRS Pharmaceuticals Key News
7.9 SFJ Pharmaceuticals Group
  7.9.1 SFJ Pharmaceuticals Group Corporate Summary
  7.9.2 SFJ Pharmaceuticals Group Business Overview
  7.9.3 SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Major Product Offerings
  7.9.4 SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Revenue in Global Market (2017-2022)
  7.9.5 SFJ Pharmaceuticals Group Key News

8 CONCLUSION


9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Nonerosive Reflux Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Nonerosive Reflux Disease Treatment Market Drivers in Global Market
Table 3. Nonerosive Reflux Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Nonerosive Reflux Disease Treatment in Global Market
Table 5. Top Nonerosive Reflux Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Nonerosive Reflux Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Nonerosive Reflux Disease Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Nonerosive Reflux Disease Treatment Product Type
Table 9. List of Global Tier 1 Nonerosive Reflux Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nonerosive Reflux Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Nonerosive Reflux Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Nonerosive Reflux Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Nonerosive Reflux Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Nonerosive Reflux Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Nonerosive Reflux Disease Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Nonerosive Reflux Disease Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Nonerosive Reflux Disease Treatment Product Offerings
Table 32. AstraZeneca Nonerosive Reflux Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Eisai Corporate Summary
Table 34. Eisai Nonerosive Reflux Disease Treatment Product Offerings
Table 35. Eisai Nonerosive Reflux Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Nonerosive Reflux Disease Treatment Product Offerings
Table 38. GlaxoSmithKline Nonerosive Reflux Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Takeda Pharmaceutical Corporate Summary
Table 40. Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Product Offerings
Table 41. Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Nonerosive Reflux Disease Treatment Product Offerings
Table 44. Johnson & Johnson Nonerosive Reflux Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Daewoong Pharmaceutical Corporate Summary
Table 46. Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Product Offerings
Table 47. Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Ironwood Pharmaceuticals Corporate Summary
Table 49. Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Product Offerings
Table 50. Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 51. SRS Pharmaceuticals Corporate Summary
Table 52. SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Product Offerings
Table 53. SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 54. SFJ Pharmaceuticals Group Corporate Summary
Table 55. SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Product Offerings
Table 56. SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Nonerosive Reflux Disease Treatment Segment by Type in 2021
Figure 2. Nonerosive Reflux Disease Treatment Segment by Application in 2021
Figure 3. Global Nonerosive Reflux Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Nonerosive Reflux Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nonerosive Reflux Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nonerosive Reflux Disease Treatment Revenue in 2021
Figure 8. By Type - Global Nonerosive Reflux Disease Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Nonerosive Reflux Disease Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Nonerosive Reflux Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Nonerosive Reflux Disease Treatment Revenue Market Share, 2017-2028
Figure 12. US Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Nonerosive Reflux Disease Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Nonerosive Reflux Disease Treatment Revenue Market Share, 2017-2028
Figure 24. China Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Nonerosive Reflux Disease Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Nonerosive Reflux Disease Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Nonerosive Reflux Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Nonerosive Reflux Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eisai Nonerosive Reflux Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Nonerosive Reflux Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Nonerosive Reflux Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)